News Archive
Issue of Equity
Eden Research, a UK leading agrochemical and development company, announces that it has issued 2,325,650 ordinary shares of 1p each pursuant to the exercise of warrants by long term lenders of the Company. The aggregate consideration of GBP 428,945 arising from the exercise of warrants will be offset against their loans.
Tim Griffiths, CEO of Eden Research plc said:
"This exercise of warrants reduces Eden Research's creditor position and it einforces the lenders' commitment to the Company. The lenders have agreed to be locked in for a period of 12 months from the date of issue."
Separately, the Company announces that it has issued 50,000 ordinary shares of 1p each pursuant to the exercise of options on 8 July 2008.
Following these issues, Eden Research has 56,226,612 ordinary shares in issue.
Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Matthew Robinson, JM Finn Capital Markets Ltd
T : 020 7600 1658
Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113
About Eden Research plc
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.
For further information please visit www.edenresearch.com.